Medication info
Atorva MZ Tablets 10/10 mg

Atorva MZ Tablets 10/10 mg

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
White, rectangular film-coated tablets
Packaging
30 tablets/Alu-Alu[(10 tablets/Alu-Alu×3)]
Approval status
Active

MFDS item code 202101650 · Approved 2021.02.18 · Insurance code 622804530

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who uses it
Adults
Adult dosage
This medicine is administered once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/10mg∼10/80mg once daily. The recommended initial dosage is 10/10mg or 10/20mg once daily. For patients who require greater LDL cholesterol reduction (55% or more), the recommended initial dosage is 10/40mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • dyslipidemia
  • hypercholesterolemia
  • atherosclerotic vascular disease
View approved original text

This medication helps to lower elevated total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL-cholesterol levels while raising HDL-cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. It can effectively manage blood cholesterol levels in patients with homozygous familial hypercholesterolemia when used alone or in combination with other therapies. This medication is particularly useful when dietary adjustments and non-drug treatments are insufficient and improves health by managing lipids in patients at high risk of vascular disease. It is important to identify secondary causes like diabetes and hypothyroidism before treatment and take necessary measures. Regular tests of lipid levels can enable treatment safely and effectively. This medication is used to improve health problems associated with hypercholesterolemia.

Dosage and Administration

Adult dosage

This medicine is administered once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/10mg∼10/80mg once daily. The recommended initial dosage is 10/10mg or 10/20mg once daily. For patients who require greater LDL cholesterol reduction (55% or more), the recommended initial dosage is 10/40mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.

Precautions

This medication can cause serious muscle problems, so patients should notify their physician immediately if symptoms like muscle pain, cramps, or weakness occur. Especially in cases of impaired kidney function, severe infections, major surgeries, or trauma, it may be necessary to temporarily discontinue or halt this medication. Patients allergic to the ingredients or with severely impaired liver function, those with muscle diseases, pregnant or nursing women should not take this medication. Patients with certain liver diseases or significantly elevated liver enzyme levels should also avoid using this medication. Caution is advised for patients with a history of alcohol addiction or liver disease, impaired kidney function, hypothyroidism, or elderly patients, as they are at higher risk for muscle problems. As this medication can interact with others, especially those affecting liver metabolism or muscles, patients should consult their physician when taking other medications. Liver function abnormalities can occur, so routine checks of liver function test results are necessary, and if symptoms of liver damage arise, use should be discontinued immediately. Blood sugar levels may increase during the use of this medication, and patients at risk for diabetes should monitor their blood sugar regularly. Women who are pregnant or may become pregnant should employ adequate contraception while taking this medication and discontinue use immediately upon confirmation of pregnancy. It is also advisable for nursing women to avoid this medication, as there is a possibility it may be excreted in breast milk. Dizziness or drowsiness may occur, so caution is necessary when driving or operating machinery. The safety and effectiveness of this medication have not been established in children, so it is not recommended. In case of overdose, there is no specific antidote, so symptomatic treatment and supportive care should be pursued, along with monitoring liver function and muscle enzyme levels.

Side effects

muscle pain, abdominal pain, elevation of liver enzymes, increased ALT, increased AST, musculoskeletal pain, dizziness, cough, nausea, joint pain, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, headache, diarrhea, pharyngitis, sinus infection, upper respiratory infection, low back pain, muscle cramps, muscle fatigue, complications due to rupture, myopathy, myositis, rhabdomyolysis, tendon disorders, muscle rupture, lupus-like syndrome, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairments, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, weakness, malaise, chest pain, peripheral edema, fatigue, fever, hyperglycemia, hypoglycemia, weight gain, loss of appetite, dyspepsia, vomiting, belching, pancreatitis, oropharyngeal pain, nosebleeds, insomnia, nightmares, paresthesia, sensory deficits, dysgeusia, amnesia, peripheral neuropathy, elevated serum creatine kinase, positive urinary leukocytes, urinary tract infection, increased frequency of urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, fibrocystic breast changes, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgency, abnormal ejaculation, uterine bleeding, colored urine, hypoglycemia, increased appetite, vasomotor edema, chest pain, angina, facial edema, fever, neck stiffness, generalized edema, amblyopia, dry eyes, refractive disorders, ocular hemorrhage, hearing loss, glaucoma, corneal opacification, loss of taste, taste distortion, leukopenia, anemia, decreased testosterone, increased cholinesterase, elevated TSH, increased ACTH, decreased aldosterone, increased potassium, elevated BUN, cerebral infarction, palpitations, tachycardia, anaphylaxis, urticaria, rash, vascular edema, joint pain, muscle pain, elevated creatine phosphokinase, myopathy, rhabdomyolysis, increased liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, dizziness, sensory abnormalities, depression, headache, cholelithiasis, cholecystitis, drug-induced liver injury, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia with systemic symptom drug reactions, erythema multiforme, fatigue, chest discomfort, edema, weakness, systemic edema, diabetic neuropathy, tremors, epigastric pain, gastritis, discomfort in the epigastrium, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, sputum, runny nose, limb pain, diabetes, splenomegaly, hyperhidrosis, conjunctival congestion, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased serum urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. Additionally, it should be kept at room temperature, between 1 and 30 degrees Celsius, to maintain its efficacy and safety.

Appearance and packaging

Appearance

White, rectangular film-coated tablets

Package unit

30 tablets/Alu-Alu[(10 tablets/Alu-Alu×3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.